← Back to Search

Home Alone Program for Cognitive Impairment

N/A

Recruiting

Led By Joseph Gaugler, PhD

Research Sponsored by University of Minnesota

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Demonstrates capacity to consent

Lives alone in a non-residential setting

Timeline

Screening 3 weeks

Treatment Varies

Follow Up phase ii at 3 months

Awards & highlights

Study Summary

This trial aims to evaluate a program to help older adults with cognitive impairment who live alone to stay safe and engaged. Participants will complete 3 surveys, 7 weekly meetings with a coach, and a final interview.

Who is the study for?

This trial is for U.S. residents aged 55 or older who live alone, can consent to participate, and have cognitive impairment (CI). They must either have a provider's diagnosis of CI, score between 13-18 on the T-MoCA test, or feel they have memory issues. Excluded are those in assisted living, non-English speakers, participants in similar services, those unwilling or unable to engage actively in the intervention, and individuals with untreated mental health conditions.Check my eligibility

What is being tested?

The 'Home Alone' program is being tested over two phases: Phase I involves a three-month commitment with weekly meetings and surveys; Phase II extends this to six months. The program aims to help cognitively impaired adults who live alone remain active and safe at home by providing coaching sessions.See study design

What are the potential side effects?

Since 'Home Alone' is not a medication but an engagement and safety program for people with cognitive impairments living alone, it does not have side effects like drugs do. However, participation requires time commitment for meetings and surveys.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I understand and can agree to medical procedures.

Select...

I live by myself in a home or apartment.

Select...

I am 55 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ phase ii at 3 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~phase ii at 3 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and phase ii at 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptability of Intervention

Feasibility of Intervention

Intervention Appropriateness

+1 more

Secondary outcome measures

Activity/Engagement

Behavioral Activation Scale

Cognition

+8 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Home Alone InterventionExperimental Treatment1 Intervention

Home Alone is a semi-structured intervention, tailored to address the individual needs and concerns of the older adult. The participant will engage in about seven psychoeducational coaching sessions, each lasting approximately one hour. The intervention has two key foci: increasing or maintaining home safety and comfort increasing scheduled social engagements and activities. Sessions are also designed to identify formal and informal services and supports to improve to increase assistance and ability to live independently for as long as safely possible. The sessions take place either in-person or remotely (via secure video conferencing or telephone). Ad hoc/ongoing sessions may be provided as needed.

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of MinnesotaLead Sponsor

1,381 Previous Clinical Trials

1,588,910 Total Patients Enrolled

Joseph Gaugler, PhDPrincipal InvestigatorUniversity of Minnesota

1 Previous Clinical Trials

500 Total Patients Enrolled

Media Library

Home Alone Clinical Trial Eligibility Overview. Trial Name: NCT05746390 — N/A

Cognitive Impairment Research Study Groups: Home Alone Intervention

Cognitive Impairment Clinical Trial 2023: Home Alone Highlights & Side Effects. Trial Name: NCT05746390 — N/A

Home Alone 2023 Treatment Timeline for Medical Study. Trial Name: NCT05746390 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the total enrollment number of this trial?

"Affirmative. The information available on clinicaltrials.gov suggests that this medical experiment, initially posted on April 15th 2023 is currently recruiting patients. 65 individuals need to be enrolled from a single location."

Answered by AI

Is this research endeavor currently looking for participants?

"Affirmative. Clinicaltrials.gov cites that this clinical trial is presently registering participants, with the initial posting on April 15th 2023 and a recent revision on May 24th 2023. The study seeks to enroll 65 patients from one medical facility."

Answered by AI

What end goals are scientists hoping to achieve by launching this experiment?

"During Phase II, which lasts for 6 months, the primary goal of this trial will be to assess the practicality of the intervention. Additional metrics such as De Jong Gierveld Loneliness Scale (Short - 6 items), Geriatric Depression Scale-Short Form -15 items and Pleasant Events Schedule: Alzheimer's disease (AD) short form will also be employed to measure emotional/social loneliness, emotional well-being and activity level respectively."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Home Alone: An Intervention for People With Cognitive Impairment Who Live Alone

2023. "Home Alone: An Intervention for People With Cognitive Impairment Who Live Alone". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05746390.

All > Dementia